Korea Investment Partners (KIP), the investment arm of financial services provider Korea Investment Holdings, has reached the final close of its fourth RMB-denominated fund at RMB1 billion (US$145.10 million) to invest in China’s biotech, healthcare and retail industries, said KIP in a statement released on its WeChat official account on December 24.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?